{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Experimental verification", "gene regulation.", "network pharmacology", "securinine", "spinal muscular atrophy", "survival motor neuron"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38561613", "DateCompleted": {"Year": "2024", "Month": "06", "Day": "27"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "27"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0113816128288504240321041408"], "ArticleDate": [], "Journal": {"ISSN": "1873-4286", "JournalIssue": {"Volume": "30", "Issue": "15", "PubDate": {"Year": "2024"}}, "Title": "Current pharmaceutical design", "ISOAbbreviation": "Curr Pharm Des"}, "ArticleTitle": "Molecular Mechanisms of Medicinal Plant <i>Securinega suffruticosa</i>-derived Compound Securinine against Spinal Muscular Atrophy based on Network Pharmacology and Experimental Verification.", "Pagination": {"StartPage": "1178", "EndPage": "1193", "MedlinePgn": "1178-1193"}, "Abstract": {"AbstractText": ["Spinal Muscular Atrophy (SMA) is a severe motor neuronal disorder with high morbidity and mortality. Securinine has shown the potential to treat SMA; however, its anti-SMA role remains unclear.", "This study aims to reveal the anti-SMA mechanisms of securinine.", "Securinine-associated targets were acquired from Herbal Ingredients' Targets (HIT), Similarity Ensemble Approach (SEA), and SuperPred. SMA-associated targets were obtained from GeneCards and Dis- GeNET. Protein-protein Interaction (PPI) network was constructed using GeneMANIA, and hug targets were screened using cytoHubba. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using ClusterProfifiler. Molecular docking was conducted using Pymol and Auto- Dock. In vitro assays were used to verify the anti-SMA effects of securinine.", "Twenty-six intersection targets of securinine and SMA were obtained. HDAC1, HDAC2, TOP2A, PIK3R1, PRMT5, JAK2, HSP90AB1, TERT, PTGS2, and PAX8 were the core targets in PPI network. GO analysis demonstrated that the intersecting targets were implicated in the regulation of proteins, steroid hormones, histone deacetylases, and DNA transcription. KEGG analysis, pathway-pathway, and hub target-pathway networks revealed that securinine might treat SMA through TNF, JAK-STAT, Ras, and PI3K-Akt pathways. Securinine had a favorable binding affinity with HDAC1, HSP90AB, JAK2, PRMT5, PTGS2, and TERT. Securinine rescued viability suppression, mitochondria damage, and SMN loss in the SMA cell model. Furthermore, securinine increased HDAC1 and PRMT5 expression, decreased PTGS2 expression, suppressed the JAK2-STAT3 pathway, and promoted the PI3K-Akt pathway.", "Securinine might alleviate SMA by elevating HDAC1 and PRMT5 expression and reducing PTGS2 via JAK2-STAT3 suppression and PI3K-Akt activation."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "NHC Key Laboratory of Preconception Health Birth in Western China, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, Department of Medical Genetics, Yunnan Provincial Clinical Research Center for Birth Defects and Rare Diseases, The First People's Hospital of Yunnan Province, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}], "LastName": "Zhang", "ForeName": "Yinhong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "NHC Key Laboratory of Preconception Health Birth in Western China, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, Department of Medical Genetics, Yunnan Provincial Clinical Research Center for Birth Defects and Rare Diseases, The First People's Hospital of Yunnan Province, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}], "LastName": "He", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}, {"Identifier": [], "Affiliation": "NHC Key Laboratory of Periconception Health Birth in Western China, Department of Reproductive Medicine, The First People's Hospital of Yunnan Province, Kunming 650032, Yunnan, China."}], "LastName": "Xiang", "ForeName": "Lifeng", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "NHC Key Laboratory of Preconception Health Birth in Western China, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, Department of Medical Genetics, Yunnan Provincial Clinical Research Center for Birth Defects and Rare Diseases, The First People's Hospital of Yunnan Province, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}], "LastName": "Tang", "ForeName": "Xinhua", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}], "LastName": "Wang", "ForeName": "Shiyu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}], "LastName": "Li", "ForeName": "Aoyu", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}], "LastName": "Wang", "ForeName": "Chaoyan", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}, {"Identifier": [], "Affiliation": "Department of Pediatrics, The First People's Hospital of Yunnan Province, Kunming 650032, Yunnan, China."}], "LastName": "Li", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "NHC Key Laboratory of Preconception Health Birth in Western China, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, Department of Medical Genetics, Yunnan Provincial Clinical Research Center for Birth Defects and Rare Diseases, The First People's Hospital of Yunnan Province, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China."}, {"Identifier": [], "Affiliation": "School of Medical, Kunming University of Science and Technology, Kunming 650500, Yunnan, China."}], "LastName": "Zhu", "ForeName": "Baosheng", "Initials": "B"}], "GrantList": [{"GrantID": "2019ZF015", "Agency": "Fund of Yunnan Provincial Clinical Research Center for Birth Defects and Rare Diseases", "Country": ""}, {"GrantID": "YNWR-MY-2018-016", "Agency": "\"Famous Doctor\" special project of the Ten Thousand People Program of Yunnan Province", "Country": ""}, {"GrantID": "202101AY070001-262", "Agency": "Co-operation Fund of Kunming Medical University and the Science and Technology Department of Yunnan Province", "Country": ""}, {"GrantID": "2020ZDKFKT001", "Agency": "Open Fund of Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases", "Country": ""}, {"GrantID": "2017HC009", "Agency": "Innovation Research Project of Human Assisted Reproductive Technology of Yunnan Province", "Country": ""}, {"GrantID": "zx2019-01-01, 2022LCZXKF-SZ02", "Agency": "Open Fund of Reproductive Obstetrics and Gynecology Clinical Center of Yunnan Province", "Country": ""}, {"GrantID": "2021YFA0805703", "Agency": "National Key Research and Development Program of China", "Country": ""}, {"GrantID": "KUST-KH2022003Z", "Agency": "Kunming University of Science and Technology & the First People's Hospital of Yunnan Province", "Country": ""}, {"GrantID": "202305AC160022", "Agency": "Yunnan Provincial Young and Middle-aged Academic and Technical Leaders Reserve Talents Program", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Pharm Des", "NlmUniqueID": "9602487", "ISSNLinking": "1381-6128"}, "ChemicalList": [{"RegistryNumber": "G4VS580P5E", "NameOfSubstance": "securinine"}, {"RegistryNumber": "0", "NameOfSubstance": "Azepines"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactones"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds, Bridged-Ring"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperidines"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Network Pharmacology"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Muscular Atrophy, Spinal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology", "chemistry", "isolation & purification"], "DescriptorName": "Azepines"}, {"QualifierName": ["pharmacology", "chemistry", "isolation & purification"], "DescriptorName": "Lactones"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Heterocyclic Compounds, Bridged-Ring"}, {"QualifierName": [], "DescriptorName": "Piperidines"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ross L.F.; Kwon J.M.; Spinal muscular atrophy: Past, present, and future. Neoreviews 2019,20(8),e437-e451", "ArticleIdList": ["10.1542/neo.20-8-e437", "31371553"]}, {"Citation": "Mercuri E.; Sumner C.J.; Muntoni F.; Darras B.T.; Finkel R.S.; Spinal muscular atrophy. Nat Rev Dis Primers 2022,8(1),52", "ArticleIdList": ["10.1038/s41572-022-00380-8", "35927425"]}, {"Citation": "Butterfield R.J.; Spinal muscular atrophy treatments, newborn screening, and the creation of a neurogenetics urgency. Semin Pediatr Neurol 2021,38,100899", "ArticleIdList": ["10.1016/j.spen.2021.100899", "34183144"]}, {"Citation": "Bozorg Qomi S.; Asghari A.; Salmaninejad A.; Mojarrad M.; Spinal muscular atrophy and common therapeutic advances. Fetal Pediatr Pathol 2019,38(3),226-238", "ArticleIdList": ["10.1080/15513815.2018.1520374", "31060440"]}, {"Citation": "Aslesh T.; Yokota T.; Restoring SMN expression: An overview of the therapeutic developments for the treatment of spinal muscular atrophy. Cells 2022,11(3),417", "ArticleIdList": ["10.3390/cells11030417", "35159227"]}, {"Citation": "James R.; Chaytow H.; Ledahawsky L.M.; Gillingwater T.H.; Revisiting the role of mitochondria in spinal muscular atrophy. Cell Mol Life Sci 2021,78(10),4785-4804", "ArticleIdList": ["10.1007/s00018-021-03819-5", "33821292"]}, {"Citation": "Gidaro T.; Servais L.; Nusinersen treatment of spinal muscular atrophy: Current knowledge and existing gaps. Dev Med Child Neurol 2019,61(1),19-24", "ArticleIdList": ["10.1111/dmcn.14027", "30221755"]}, {"Citation": "Hoy S.M.; Onasemnogene abeparvovec: First global approval. Drugs 2019,79(11),1255-1262", "ArticleIdList": ["10.1007/s40265-019-01162-5", "31270752"]}, {"Citation": "Cleary Y.; Gertz M.; Grimsey P.; G\u00fcnther A.; Heinig K.; Ogungbenro K.; Aarons L.; Galetin A.; Kletzl H.; Model-based drug\u2013drug interaction extrapolation strategy from adults to children: Risdiplam in pediatric patients with spinal muscular atrophy. Clin Pharmacol Ther 2021,110(6),1547-1557", "ArticleIdList": ["10.1002/cpt.2384", "34347881"]}, {"Citation": "Kang P.; Wu Z.; Zhong Y.; Wang Z.; Zhou C.; Huo S.; Guo H.; Li S.; Xu K.; Liu L.; Chen S.; Tang H.; Wang H.; A network pharmacology and molecular docking strategy to explore potential targets and mechanisms underlying the effect of curcumin on osteonecrosis of the femoral head in systemic lupus erythematosus. BioMed Res Int 2021,2021,1-14", "ArticleIdList": ["10.1155/2021/5538643", "34557547"]}, {"Citation": "Ullah R.; Alqahtani A.S.; GC-MS Analysis, heavy metals, biological, and toxicological evaluation of Reseda muricata and Marrubium vulgare methanol extracts. Evid Based Complement Alternat Med 2022,2022,1-9", "ArticleIdList": ["10.1155/2022/2284328", "35356243"]}, {"Citation": "Leonoudakis D.; Rane A.; Angeli S.; Lithgow G.J.; Andersen J.K.; Chinta S.J.; Anti-inflammatory and neuroprotective role of natural product securinine in activated glial cells: Implications for Parkinson\u2019s disease. Mediators Inflamm 2017,2017,1-11", "ArticleIdList": ["10.1155/2017/8302636", "28473732"]}, {"Citation": "Zhang D.; Liu H.; Yang B.; Hu J.; Cheng Y.; L-securinine inhibits cell growth and metastasis of human androgen-independent prostate cancer DU145 cells via regulating mitochondrial and AGTR1/MEK/ERK/STAT3/PAX2 apoptotic pathways. Biosci Rep 2019,39(5),BSR20190469", "ArticleIdList": ["10.1042/BSR20190469", "30975734"]}, {"Citation": "Wu Z.L.; Huang X.J.; Xu M.T.; Ma X.; Li L.; Shi L.; Wang W.J.; Jiang R.W.; Ye W.C.; Wang Y.; Flueggeacosines A\u2013C, dimeric securinine-type alkaloid analogues with neuronal differentiation activity from Flueggea suffruticosa. Org Lett 2018,20(23),7703-7707", "ArticleIdList": ["10.1021/acs.orglett.8b03432", "30484660"]}, {"Citation": "Chen Y.C.; Chang J.G.; Liu T.Y.; Jong Y.J.; Cheng W.L.; Yuo C.Y.; Securinine enhances SMN2 exon 7 inclusion in spinal muscular atrophy cells. Biomed Pharmacother 2017,88,708-714", "ArticleIdList": ["10.1016/j.biopha.2017.01.104", "28152480"]}, {"Citation": "Yuan H.; Ma Q.; Cui H.; Liu G.; Zhao X.; Li W.; Piao G.; How can synergism of traditional medicines benefit from network pharmacology? Molecules 2017,22(7),1135", "ArticleIdList": ["10.3390/molecules22071135", "28686181"]}, {"Citation": "Xu S.; Wang L.; Pan X.; An evaluation of combined strategies for improving the performance of molecular docking. J Bioinform Comput Biol 2021,19(2),2150003", "ArticleIdList": ["10.1142/S0219720021500037", "33641636"]}, {"Citation": "Yan D.; Zheng G.; Wang C.; Chen Z.; Mao T.; Gao J.; Yan Y.; Chen X.; Ji X.; Yu J.; Mo S.; Wen H.; Han W.; Zhou M.; Wang Y.; Wang J.; Tang K.; Cao Z.; HIT 2.0: An enhanced platform for herbal ingredients\u2019. Nucleic Acids Res 2022,50(D1),D1238-D1243", "ArticleIdList": ["10.1093/nar/gkab1011", "34986599"]}, {"Citation": "Keiser M.J.; Roth B.L.; Armbruster B.N.; Ernsberger P.; Irwin J.J.; Shoichet B.K.; Relating protein pharmacology by ligand chemistry. Nat Biotechnol 2007,25(2),197-206", "ArticleIdList": ["10.1038/nbt1284", "17287757"]}, {"Citation": "Gallo K.; Goede A.; Preissner R.; Gohlke B.O.; SuperPred 3.0: Drug classification and target prediction-a machine learning approach. Nucleic Acids Res 2022,50(W1),W726-W731", "ArticleIdList": ["10.1093/nar/gkac297", "35524552"]}, {"Citation": "Bateman A.; Martin M-J.; Orchard S.; Magrane M.; Agivetova R.; Ahmad S.; Alpi E.; Bowler-Barnett E.H.; Britto R.; Bursteinas B.; Bye-A-Jee H.; Coetzee R.; Cukura A.; Da Silva A.; Denny P.; Dogan T.; Ebenezer T.G.; Fan J.; Castro L.G.; Garmiri P.; Georghiou G.; Gonzales L.; Hatton-Ellis E.; Hussein A.; Ignatchenko A.; Insana G.; Ishtiaq R.; Jokinen P.; Joshi V.; Jyothi D.; Lock A.; Lopez R.; Luciani A.; Luo J.; Lussi Y.; MacDougall A.; Madeira F.; Mahmoudy M.; Menchi M.; Mishra A.; Moulang K.; Nightingale A.; Oliveira C.S.; Pundir S.; Qi G.; Raj S.; Rice D.; Lopez M.R.; Saidi R.; Sampson J.; Sawford T.; Speretta E.; Turner E.; Tyagi N.; Vasudev P.; Volynkin V.; Warner K.; Watkins X.; Zaru R.; Zellner H.; Bridge A.; Poux S.; Redaschi N.; Aimo L.; Argoud-Puy G.; Auchincloss A.; Axelsen K.; Bansal P.; Baratin D.; Blatter M-C.; Bolleman J.; Boutet E.; Breuza L.; Casals-Casas C.; de Castro E.; Echioukh K.C.; Coudert E.; Cuche B.; Doche M.; Dornevil D.; Estreicher A.; Famiglietti M.L.; Feuermann M.; Gasteiger E.; Gehant S.; Gerritsen V.; Gos A.; Gruaz-Gumowski N.; Hinz U.; Hulo C.; Hyka-Nouspikel N.; Jungo F.; Keller G.; Kerhornou A.; Lara V.; Le Mercier P.; Lieberherr D.; Lombardot T.; Martin X.; Masson P.; Morgat A.; Neto T.B.; Paesano S.; Pedruzzi I.; Pilbout S.; Pourcel L.; Pozzato M.; Pruess M.; Rivoire C.; Sigrist C.; Sonesson K.; Stutz A.; Sundaram S.; Tognolli M.; Verbregue L.; Wu C.H.; Arighi C.N.; Arminski L.; Chen C.; Chen Y.; Garavelli J.S.; Huang H.; Laiho K.; McGarvey P.; Natale D.A.; Ross K.; Vinayaka C.R.; Wang Q.; Wang Y.; Yeh L-S.; Zhang J.; Ruch P.; Teodoro D.; UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res 2021,49(D1),D480-D489", "ArticleIdList": ["10.1093/nar/gkaa1100", "33237286"]}, {"Citation": "Safran M.; Dalah I.; Alexander J.; Rosen N.; Iny Stein T.; Shmoish M.; Nativ N.; Bahir I.; Doniger T.; Krug H.; Sirota-Madi A.; Olender T.; Golan Y.; Stelzer G.; Harel A.; Lancet D.; GeneCards Version 3: The human gene integrator. Database (Oxford) 2010,2010(0),baq020", "ArticleIdList": ["10.1093/database/baq020", "20689021"]}, {"Citation": "Pi\u00f1ero J.; Ram\u00edrez-Anguita J.M.; Sa\u00fcch-Pitarch J.; Ronzano F.; Centeno E.; Sanz F.; Furlong L.I.; The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 2020,48(D1),D845-D855", "ArticleIdList": ["31680165"]}, {"Citation": "Franz M.; Rodriguez H.; Lopes C.; Zuberi K.; Montojo J.; Bader G.D.; Morris Q.; GeneMANIA update 2018. Nucleic Acids Res 2018,46(W1),W60-W64", "ArticleIdList": ["10.1093/nar/gky311", "29912392"]}, {"Citation": "Chin C.H.; Chen S.H.; Wu H.H.; Ho C.W.; Ko M.T.; Lin C.Y.; cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 2014,8(S4)(Suppl. 4),S11", "ArticleIdList": ["10.1186/1752-0509-8-S4-S11", "25521941"]}, {"Citation": "Chen L.; Zhang Y.H.; Wang S.; Zhang Y.; Huang T.; Cai Y.D.; Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLoS One 2017,12(9),e0184129", "ArticleIdList": ["10.1371/journal.pone.0184129", "28873455"]}, {"Citation": "Yang M.; Chen J.; Xu L.; Shi X.; Zhou X.; An R.; Wang X.; A network pharmacology approach to uncover the molecular mechanisms of herbal formula Ban-Xia-Xie-Xin-Tang. Evid Based Complement Alternat Med 2018,2018,1-22", "ArticleIdList": ["10.1155/2018/4050714", "30410554"]}, {"Citation": "Nicolau S.; Waldrop M.A.; Connolly A.M.; Mendell J.R.; Spinal muscular atrophy. Semin Pediatr Neurol 2021,37,100878", "ArticleIdList": ["10.1016/j.spen.2021.100878", "33892848"]}, {"Citation": "Barkats M.; SMA: From gene discovery to gene therapy. Med Sci (Paris) 2020,36(2),137-140", "ArticleIdList": ["10.1051/medsci/2020010", "32129749"]}, {"Citation": "Kwak S.C.; Jeong D.H.; Cheon Y.H.; Lee C.H.; Yoon K.H.; Kim J.Y.; Lee M.S.; Securinine suppresses osteoclastogenesis and ameliorates inflammatory bone loss. Phytother Res 2020,34(11),3029-3040", "ArticleIdList": ["10.1002/ptr.6735", "32510717"]}, {"Citation": "Klochkov S.; Neganova M.; Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs. RSC Adv 2021,11(31),19185-19195", "ArticleIdList": ["10.1039/D1RA02558A", "35478659"]}, {"Citation": "Liu C.J.; Fan X.D.; Jiang J.G.; Chen Q.X.; Zhu W.; Potential anticancer activities of securinine and its molecular targets. Phytomedicine 2022,106,154417", "ArticleIdList": ["10.1016/j.phymed.2022.154417", "36063584"]}, {"Citation": "Xiao H.; Zhang Q.; Zhong P.; Tang G.; Tao L.; Huang Z.; Guo D.; Liao Y.; Peng Y.; Wu Z.L.; Wang Y.; Ye W.C.; Shi L.; Securinine promotes neuronal development and exhibits antidepressant-like effects via mtor activation. ACS Chem Neurosci 2021,12(19),3650-3661", "ArticleIdList": ["10.1021/acschemneuro.1c00381", "34541857"]}, {"Citation": "Hou W.; Huang H.; Wu X.Q.; Lan J.X.; Bioactivities and mechanism of action of securinega alkaloids derivatives reported prior to 2022. Biomed Pharmacother 2023,158,114190", "ArticleIdList": ["10.1016/j.biopha.2022.114190", "36916441"]}, {"Citation": "Beutler J.A.; Karbon E.W.; Brubaker A.N.; Malik R.; Curtis D.R.; Enna S.J.; Securinine alkaloids: A new class of GABA receptor antagonist. Brain Res 1985,330(1),135-140", "ArticleIdList": ["10.1016/0006-8993(85)90014-9", "2985189"]}, {"Citation": "Shipman M.; Lubick K.; Fouchard D.; Guram R.; Grieco P.; Jutila M.; Dratz E.A.; Proteomic and systems biology analysis of monocytes exposed to securinine, a GABA(A) receptor antagonist and immune adjuvant. PLoS One 2012,7(9),e41278", "ArticleIdList": ["10.1371/journal.pone.0041278", "23028424"]}, {"Citation": "Abdelkader H.A.; Amin I.; Rashed L.A.; Samir M.; Ezzat M.; Histone deacetylase 1 in patients with Alopecia areata and Acne vulgaris: An epigenetic alteration. Australas J Dermatol 2022,63(2),e138-e141", "ArticleIdList": ["10.1111/ajd.13784", "35076083"]}, {"Citation": "Smalley J.P.; Baker I.M.; Pytel W.A.; Lin L.Y.; Bowman K.J.; Schwabe J.W.R.; Cowley S.M.; Hodgkinson J.T.; Optimization of class I histone deacetylase PROTACs reveals that HDAC1/2 degradation is critical to induce apoptosis and cell arrest in cancer cells. J Med Chem 2022,65(7),5642-5659", "ArticleIdList": ["10.1021/acs.jmedchem.1c02179", "35293758"]}, {"Citation": "Pagliarini V.; Guerra M.; Di Rosa V.; Compagnucci C.; Sette C.; Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in spinal muscular atrophy cells. J Neurochem 2020,153(2),264-275", "ArticleIdList": ["10.1111/jnc.14935", "31811660"]}, {"Citation": "Liimatainen K.; Huttunen R.; Latonen L.; Ruusuvuori P.; Convolutional neural network-based artificial intelligence for classification of protein localization patterns. Biomolecules 2021,11(2),264", "ArticleIdList": ["10.3390/biom11020264", "33670112"]}, {"Citation": "Wu S.; Li Y.L.; Cheng N.Y.; Wang C.; Dong E.L.; Lu Y.Q.; Li J.J.; Guo X.X.; Lin X.; Lai L.L.; Liu Z.W.; Wang N.; Chen W.J.; c.835-5T>G Variant in SMN1 gene causes transcript exclusion of Exon 7 and Spinal muscular atrophy. J Mol Neurosci 2018,65(2),196-202", "ArticleIdList": ["10.1007/s12031-018-1079-1", "29799103"]}, {"Citation": "Day J.W.; Howell K.; Place A.; Long K.; Rossello J.; Kertesz N.; Nomikos G.; Advances and limitations for the treatment of spinal muscular atrophy. BMC Pediatr 2022,22(1),632", "ArticleIdList": ["10.1186/s12887-022-03671-x", "36329412"]}, {"Citation": "Reilly A.; Chehade L.; Kothary R.; Curing SMA: Are we there yet? Gene Ther 2023,30(1-2),8-17", "ArticleIdList": ["10.1038/s41434-022-00349-y", "35614235"]}, {"Citation": "Janzen E.; Mendoza-Ferreira N.; Hosseinibarkooie S.; Schneider S.; Hupperich K.; Tschanz T.; Grysko V.; Riessland M.; Hammerschmidt M.; Rigo F.; Bennett C.F.; Kye M.J.; Torres-Benito L.; Wirth B.; CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis. Brain 2018,141(8),2343-2361", "ArticleIdList": ["10.1093/brain/awy167", "29961886"]}, {"Citation": "Berciano M.T.; Castillo-Iglesias M.S.; Val-Bernal J.F.; Lafarga V.; Rodriguez-Rey J.C.; Lafarga M.; Tapia O.; Mislocalization of SMN from the I-band and M-band in human skeletal myofibers in spinal muscular atrophy associates with primary structural alterations of the sarcomere. Cell Tissue Res 2020,381(3),461-478", "ArticleIdList": ["10.1007/s00441-020-03236-3", "32676861"]}, {"Citation": "McLeod V.M.; Chiam M.D.F.; Lau C.L.; Rupasinghe T.W.; Boon W.C.; Turner B.J.; Dysregulation of steroid hormone receptors in motor neurons and glia associates with disease progression in ALS Mice. Endocrinology 2020,161(9),bqaa113", "ArticleIdList": ["10.1210/endocr/bqaa113", "32621747"]}, {"Citation": "Wan B.; Feng P.; Guan Z.; Sheng L.; Liu Z.; Hua Y.; A severe mouse model of spinal muscular atrophy develops early systemic inflammation. Hum Mol Genet 2018,27(23),4061-4076", "ArticleIdList": ["10.1093/hmg/ddy300", "30137324"]}, {"Citation": "Thomas E.A.; D\u2019Mello S.R.; Complex neuroprotective and neurotoxic effects of histone deacetylases. J Neurochem 2018,145(2),96-110", "ArticleIdList": ["10.1111/jnc.14309", "29355955"]}, {"Citation": "Lai J.I.; Leman L.J.; Ku S.; Vickers C.J.; Olsen C.A.; Montero A.; Ghadiri M.R.; Gottesfeld J.M.; Cyclic tetrapeptide HDAC inhibitors as potential therapeutics for spinal muscular atrophy: Screening with iPSC-derived neuronal cells. Bioorg Med Chem Lett 2017,27(15),3289-3293", "ArticleIdList": ["10.1016/j.bmcl.2017.06.027", "28648462"]}, {"Citation": "Raffaele S.; Lombardi M.; Verderio C.; Fumagalli M.; TNF production and release from microglia via extracellular vesicles: Impact on brain functions. Cells 2020,9(10),2145", "ArticleIdList": ["10.3390/cells9102145", "32977412"]}, {"Citation": "Hanna A.; Frangogiannis N.G.; Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc Drugs Ther 2020,34(6),849-863", "ArticleIdList": ["10.1007/s10557-020-07071-0", "32902739"]}, {"Citation": "Ando S.; Osanai D.; Takahashi K.; Nakamura S.; Shimazawa M.; Hara H.; Survival motor neuron protein regulates oxidative stress and inflammatory response in microglia of the spinal cord in spinal muscular atrophy. J Pharmacol Sci 2020,144(4),204-211", "ArticleIdList": ["10.1016/j.jphs.2020.09.001", "33070839"]}, {"Citation": "Yin Q.; Wang L.; Yu H.; Chen D.; Zhu W.; Sun C.; Pharmacological effects of polyphenol phytochemicals on the JAK-STAT signaling pathway. Front Pharmacol 2021,12,716672", "ArticleIdList": ["10.3389/fphar.2021.716672", "34539403"]}, {"Citation": "Yan Z.; Gibson S.A.; Buckley J.A.; Qin H.; Benveniste E.N.; Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. Clin Immunol 2018,189,4-13", "ArticleIdList": ["10.1016/j.clim.2016.09.014", "27713030"]}, {"Citation": "Dai J.; Xu L.J.; Han G.D.; Sun H.L.; Zhu G.T.; Jiang H.T.; Yu G.Y.; Tang X.M.; MicroRNA-125b promotes the regeneration and repair of spinal cord injury through regulation of JAK/STAT pathway. Eur Rev Med Pharmacol Sci 2018,22(3),582-589", "ArticleIdList": ["29461585"]}, {"Citation": "Yoshino H.; Yin G.; Kawaguchi R.; Popov K.I.; Temple B.; Sasaki M.; Kofuji S.; Wolfe K.; Kofuji K.; Okumura K.; Randhawa J.; Malhotra A.; Majd N.; Ikeda Y.; Shimada H.; Kahoud E.R.; Haviv S.; Iwase S.; Asara J.M.; Campbell S.L.; Sasaki A.T.; Identification of lysine methylation in the core GTPase domain by GoMADScan. PLoS One 2019,14(8),e0219436", "ArticleIdList": ["10.1371/journal.pone.0219436", "31390367"]}, {"Citation": "Pompura S.L.; Dominguez-Villar M.; The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function. J Leukoc Biol 2018,103(6),1065-1076", "ArticleIdList": ["10.1002/JLB.2MIR0817-349R", "29357116"]}, {"Citation": "Sansa A.; de la Fuente S.; Comella J.X.; Garcera A.; Soler R.M.; Intracellular pathways involved in cell survival are deregulated in mouse and human spinal muscular atrophy motoneurons. Neurobiol Dis 2021,155,105366", "ArticleIdList": ["10.1016/j.nbd.2021.105366", "33845129"]}, {"Citation": "Chen J.S.; Wang H.K.; Hsu C.Y.; Su Y.T.; Chen J.S.; Liang C.L.; Hsieh P.C.H.; Wu C.C.; Kwan A.L.; HDAC1 deregulation promotes neuronal loss and deficit of motor function in stroke pathogenesis. Sci Rep 2021,11(1),16354", "ArticleIdList": ["10.1038/s41598-021-95837-3", "34381129"]}, {"Citation": "Kumar V.; Kundu S.; Singh A.; Singh S.; Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: Current targets and future perspective. Curr Neuropharmacol 2022,20(1),158-178", "ArticleIdList": ["10.2174/1570159X19666210609160017", "34151764"]}, {"Citation": "Tao C.C.; Hsu W.L.; Ma Y.L.; Cheng S.J.; Lee E.H.Y.; Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against A\u03b2 toxicity in a mouse model of Alzheimer\u2019s disease. Cell Death Differ 2017,24(4),597-614", "ArticleIdList": ["10.1038/cdd.2016.161", "28186506"]}, {"Citation": "Zhang H.; Yin X.; Zhang X.; Zhou M.; Xu W.; Wei Z.; Song C.; Han S.; Han W.; HSP90AB1 promotes the proliferation, migration, and glycolysis of head and neck squamous cell carcinoma. Technol Cancer Res Treat 2022,21", "ArticleIdList": ["10.1177/15330338221118202", "35929142"]}, {"Citation": "Siebert A.; Gattringer V.; Weishaupt J.H.; Behrends C.; ALS-linked loss of Cyclin-F function affects HSP90. Life Sci Alliance 2022,5(12),e202101359", "ArticleIdList": ["10.26508/lsa.202101359", "36114006"]}, {"Citation": "Gonzalez-Rodriguez M.; Villar-Conde S.; Astillero-Lopez V.; Villanueva-Anguita P.; Ubeda-Banon I.; Flores-Cuadrado A.; Martinez-Marcos A.; Saiz-Sanchez D.; Neurodegeneration and astrogliosis in the human CA1 hippocampal subfield are related to hsp90ab1 and bag3 in Alzheimer\u2019s disease. Int J Mol Sci 2021,23(1),165", "ArticleIdList": ["10.3390/ijms23010165", "35008592"]}, {"Citation": "Zhu H.; Jian Z.; Zhong Y.; Ye Y.; Zhang Y.; Hu X.; Pu B.; Gu L.; Xiong X.; Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2/STAT3 pathway inhibition. Front Immunol 2021,12,714943", "ArticleIdList": ["10.3389/fimmu.2021.714943", "34367186"]}, {"Citation": "Xu M.; Ni H.; Xu L.; Shen H.; Deng H.; Wang Y.; Yao M.; B14 ameliorates bone cancer pain through downregulating spinal interleukin-1\u03b2 via suppressing neuron JAK2/STAT3 pathway. Mol Pain 2019,15", "ArticleIdList": ["10.1177/1744806919886498", "31615322"]}, {"Citation": "Xiong J.; Zhou H.; Lu D.; Wang Z.; Liu H.; Sun Y.; Xu J.; Feng Y.; Xing A.; Levetiracetam Reduces early inflammatory response after experimental intracerebral hemorrhage by regulating the Janus Kinase 2 (JAK2)\u2013Signal Transducer and Activator of Transcription 3 (STAT3) signaling pathway. Med Sci Monit 2020,26,e922741", "ArticleIdList": ["10.12659/MSM.922741", "32289810"]}, {"Citation": "Yang H.; Wang H.; Shu Y.; Li X.; miR-103 promotes neurite outgrowth and suppresses cells apoptosis by targeting prostaglandin-endoperoxide synthase 2 in cellular models of Alzheimer\u2019s disease. Front Cell Neurosci 2018,12,91", "ArticleIdList": ["10.3389/fncel.2018.00091", "29674956"]}, {"Citation": "Zhuang J.; Chen Z.; Cai P.; Wang R.; Yang Q.; Li L.; Yang H.; Zhu R.; Targeting MicroRNA-125b Promotes neurite outgrowth but represses cell apoptosis and inflammation via blocking PTGS2 and CDK5 in a FOXQ1-dependent way in Alzheimer disease. Front Cell Neurosci 2020,14,587747", "ArticleIdList": ["10.3389/fncel.2020.587747", "33408612"]}, {"Citation": "Chen Y.; Shao X.; Zhao X.; Ji Y.; Liu X.; Li P.; Zhang M.; Wang Q.; Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms. Biomed Pharmacother 2021,144,112252", "ArticleIdList": ["10.1016/j.biopha.2021.112252", "34619493"]}, {"Citation": "Yuan Y.; Nie H.; Protein arginine methyltransferase 5: A potential cancer therapeutic target. Cell Oncol (Dordr) 2021,44(1),33-44", "ArticleIdList": ["10.1007/s13402-020-00577-7", "33469838"]}, {"Citation": "Lanfranco M.; Vassallo N.; Cauchi R.J.; Spinal muscular atrophy: From defective chaperoning of snRNP assembly to neuromuscular dysfunction. Front Mol Biosci 2017,4,41", "ArticleIdList": ["10.3389/fmolb.2017.00041", "28642865"]}, {"Citation": "Shim H.S.; Horner J.W.; Wu C.J.; Li J.; Lan Z.D.; Jiang S.; Xu X.; Hsu W.H.; Zal T.; Flores I.I.; Deng P.; Lin Y.T.; Tsai L.H.; Wang Y.A.; DePinho R.A.; Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer\u2019s disease models. Nature Aging 2021,1(12),1162-1174", "ArticleIdList": ["10.1038/s43587-021-00146-z", "35036927"]}, {"Citation": "McKelvey B.A.; Umbricht C.B.; Zeiger M.A.; Telomerase Reverse Transcriptase (TERT) regulation in thyroid cancer: A review. Front Endocrinol (Lausanne) 2020,11,485", "ArticleIdList": ["10.3389/fendo.2020.00485", "32849278"]}, {"Citation": "Zou Y.; Cong Y.; Zhou J.; Implications of telomerase reverse transcriptase in tumor metastasis. BMB Rep 2020,53(9),458-465", "ArticleIdList": ["10.5483/BMBRep.2020.53.9.108", "32731912"]}, {"Citation": "Singh R.N.; Howell M.D.; Ottesen E.W.; Singh N.N.; Diverse role of survival motor neuron protein. Biochim Biophys Acta Gene Regul Mech 2017,1860(3),299-315", "ArticleIdList": ["10.1016/j.bbagrm.2016.12.008", "28095296"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "24"}, {"Year": "2024", "Month": "3", "Day": "5"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "12", "Minute": "43"}, {"Year": "2024", "Month": "4", "Day": "2", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "4", "Day": "1", "Hour": "23", "Minute": "33"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38561613", "10.2174/0113816128288504240321041408", "CPD-EPUB-139441"]}}]}